MedPath

Avicenna Research Institute

Avicenna Research Institute logo
Iran
Ownership
Private
Established
1998-01-01
Employees
-
Market Cap
-
Website
http://www.ari.ir

Clinical Trials

11

Active:0
Completed:4

Trial Phases

4 Phases

Phase 1:2
Phase 2:1
Phase 3:2
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (11 trials with phase data)• Click on a phase to view related trials

Not Applicable
6 (54.5%)
Phase 1
2 (18.2%)
Phase 3
2 (18.2%)
Phase 2
1 (9.1%)

Menstrual Blood Stem Cells in Poor Ovarian Responders

Phase 3
Completed
Conditions
Poor Ovarian Response
Infertility, Female
First Posted Date
2023-01-30
Last Posted Date
2023-01-30
Lead Sponsor
Avicenna Research Institute
Target Recruit Count
180
Registration Number
NCT05703308
Locations
🇮🇷

Avicenna Research Institute, Tehran, Iran, Islamic Republic of

Menstrual Blood Stem Cells in Severe Covid-19

Phase 1
Completed
Conditions
Covid19
Cytokine Storm
First Posted Date
2021-08-24
Last Posted Date
2021-09-02
Lead Sponsor
Avicenna Research Institute
Target Recruit Count
29
Registration Number
NCT05019287
Locations
🇮🇷

Avicenna Research Institute, Tehran, Iran, Islamic Republic of

News

No news found
© Copyright 2025. All Rights Reserved by MedPath